Syschem (India) Limited (BOM:531173)

India flag India · Delayed Price · Currency is INR
50.94
-0.20 (-0.39%)
At close: Apr 28, 2026
27.70%
Market Cap 2.50B
Revenue (ttm) 5.45B
Net Income (ttm) 82.03M
Shares Out 49.01M
EPS (ttm) 1.47
PE Ratio 34.59
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,907
Average Volume 25,884
Open 51.15
Previous Close 51.14
Day's Range 50.20 - 51.15
52-Week Range 36.11 - 62.00
Beta -0.67
RSI 59.44
Earnings Date May 7, 2026

About Syschem (India)

Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialty solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and ... [Read more]

Industry Industrial Organic Chemicals
Founded 1993
Employees 115
Stock Exchange Bombay Stock Exchange
Ticker Symbol 531173
Full Company Profile

Financial Performance

In fiscal year 2025, Syschem (India)'s revenue was 3.86 billion, an increase of 65.43% compared to the previous year's 2.33 billion. Earnings were 4.60 million, a decrease of -83.34%.

Financial Statements

News

There is no news available yet.